XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (28,836) $ (25,565)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 3,551 2,512
Net (accretion) amortization on available-for-sale securities (1,040) 118
Accretion of final payment fee on term loan 87 121
Amortization of debt issuance costs 132 75
Loss on extinguishment of term loan facility 1,208  
Noncash operating lease expense 41  
Depreciation 14 18
Changes in operating assets and liabilities:    
Prepaid and other current assets (4,599) 1,942
Other assets   (72)
Accounts payable 4,225 (2,422)
Accrued expenses (4,827) (1,215)
Operating lease liability (41)  
Net cash used in operating activities (30,085) (24,344)
Cash flows from investing activities:    
Proceeds from sales and maturities of available-for-sale securities 37,880 36,179
Purchases of available-for-sale securities (33,774) (9,401)
Purchases of property and equipment   (6)
Net cash (used in) provided by investing activities 4,106 26,772
Cash flows from financing activities:    
Proceeds from issuance of common stock in public offering, net of issuance costs 296,817  
Proceeds from term loan facility, net of issuance costs 24,363  
Proceeds from issuance of common stock in at-the-market public offering, net of issuance costs 13,422  
Proceeds from issuance of common stock upon exercise of warrants 8,960  
Proceeds from issuance of common stock upon exercise of stock options 185 29
Payment of withholding taxes related to restricted stock units (693)  
Payment of term loan facility, including final payment (21,400)  
Net cash provided by financing activities 321,654 29
Net change in cash and cash equivalents, and restricted cash 295,675 2,457
Cash and cash equivalents, and restricted cash at beginning of period 55,255 52,457
Cash and cash equivalents, and restricted cash at end of period 350,930 54,914
Components of cash and cash equivalents, and restricted cash:    
Cash and cash equivalents 350,930 54,889
Restricted cash   25
Total cash and cash equivalents, and restricted cash 350,930 54,914
Supplemental disclosures of cash information:    
Cash paid for interest 542 $ 169
Cash paid for operating leases 47  
Supplemental disclosures of noncash information:    
Issuance of common stock warrants in connection with term loan $ 482